< The 2014 All-America Research TeamDavid LewisMorgan StanleyFirst-place appearances: 0
Total appearances: 3
Team debut: 2012For a third year running, David Lewis of Morgan Stanley wins third-place honors on this lineup. “David has a great team and very thoroughly explains his positions,” one investor cheers. “He is also not afraid to change his position when new information is presented.” The analyst is touting Boston Scientific Corp. of Marlborough, Massachusetts. “It is trading at a discount to its peers, which does not reflect its underappreciated leverage potential,” explains Lewis. “We see incremental organic growth acceleration on the company’s emerging pipeline, and we are more out of consensus on the company’s ability to drive double-digit earnings-per-share growth relative to peers, due to the company’s structural cost position.” He believes that Boston Scientific’s fundamentals justify a share price of $15, which implies a 21.1 percent upside to their mid-September value.